Skip to main content

Table 1 Parameter values for base case and sensitivity analyses

From: Cost-effectiveness of programs to eliminate disparities in elderly vaccination rates in the United States

  

Parameter range

  

Description

Base

Low

High

Distribution

Source

Probabilities

     

  Influenza and PPSVa vaccination

Figure 2

-50%

+50%

Triangle

[Figure 2]

  Vaccination side effects (local reactions)

0.13

0.06

0.20

Beta

[23]

  Influenza

     

   Annual risk

0.10

0.03

0.21

Beta

[24]

   Vaccine effectiveness

0.58

0.34

0.74

Beta

[25]

   Clinic visit, given influenza

0.62

0.52

0.72

Beta

[26]

   Hospitalization, given influenza

0.04

0.01

0.07

Beta

[26]

   Increased risk of IPDb given influenza

0.10

0.08

0.13

Beta

[24]

   Death given influenza hospitalization

0.23

0.18

0.28

Beta

[1, 2]

  IPD

     

   Incidence, disability, mortality

Table 2

-20%

+20%

Triangular

[3], Estimate

   Immunocompromised in cohort (%)

Table 2

-20%

+20%

Triangular

[3], Estimate

   Vaccine serotype coverage (%)

Table 2

-20%

+20%

Triangular

[3], Estimate

   PPSV vaccine effectiveness (yr post-vaccination)

   

Triangular

[27]

    Year 1

0.80

0.60

0.90

  

    Year 5

0.58

0.31

0.80

  

    Year 10

0.00

0.00

0.10

  

  Excess mortality due to disability (per year)

0.1

0.0

1.0

Triangular

[24]

Costs

     

Vaccination program, per targeted elder per year

Figure 2

-50%

+50%

Triangular

[Figure 2]

Influenza vaccine and administration

$20.97

$13.11

$28.83

Gamma

[28]

PPSV and administration

$33.47

$16.74

$55.79

Gamma

[24]

Vaccine side effect treatment

$0.76

$0.68

$4.01

Gamma

[28]

Influenza and IPD symptomatic treatment

$5.00

$0.00

$10.00

Gamma

[Estimate]

Influenza

     

Seeking clinic care

$67.19

$56.62

$77.76

Gamma

[28]

Clinic visit

$158.72

$120.51

$196.92

Gamma

[28]

Hospitalization without death

$5,001

$4,714

$5,406

Gamma

[28]

Hospitalization with death

$10,244

$9,432

$11,173

Gamma

[28]

IPD

     

Hospitalization without death

$27,357

$25,224

$30,093

Gamma

[24]

Hospitalization with death

$37,688

$33,919

$41,458

Gamma

[24]

Disability (annual)

$12,683

$10,451

$14,914

Gamma

[29]

Durations

     

Vaccine side effects (days)

3

1

8

Gamma

[30]

Influenza, outpatient (days)

7

3

10

Gamma

[31]

Influenza, prior to seeking inpatient care (days)

2

1

3

Gamma

[Estimate]

Influenza, inpatient (days)

7

4

10

Gamma

[1]

IPD inpatient (days)

12

9

15

Gamma

[32]

Utilities

     

One year of healthy life for >65 yr old (QALY)

   

Uniform

[33, 34]

65-70 years

0.76

0.71

0.81

  

70-75 years

0.74

0.69

0.79

  

75-80 years

0.70

0.65

0.75

  

80-85 years

0.63

0.58

0.68

  

>85 years

0.51

0.46

0.56

  

Vaccine side effects

0.95

0.71

1.00

Uniform

[28]

Influenza, outpatient

0.65

0.49

0.81

Uniform

[28]

Influenza, inpatient

0.50

0.38

0.63

Uniform

[28]

IPD, inpatient

0.20

0.15

0.25

Uniform

[32]

IPD, disabled

0.40

0.20

0.60

Uniform

[35], Estimate

  1. aPneumococcal polysaccharide vaccine.
  2. bInvasive pneumococcal disease.